To our valued Kinarm Lab users, collaborators and followers,
Today, June 27, 2019 is the day we announce our new company name: Kinarm.
Attending RehabWeek?
Customers of BKIN Technologies can receive preferential registration rates for the upcoming RehabWeek conference in Toronto, June 2019.
In order to apply the membership discount, please proceed as follows:
- Choose that you are a member of IISART during the registration process (https://www.rehabweek.org/registration/)
- Enter the company-specific code IISART-BKIN-182584
- When asked which conference you mainly plan to attend, choose INRS. This does not mean you cannot attend other conferences during the RehabWeek, but it helps to allocate resources.
Please feel free to share the code.
BKIN’s Founder & CSO featured in Queen’s School of Medicine Report – 2018
Dean Richard Reznick, head of the Queen’s School of Medicine has just posted his annual report. In it he recognizes the research program and contributions of BKIN’s CSO and co-founder Dr. Stephen Scott. Congrats Steve!
World Stroke Congress visitors: please reach out
To all of the wonderful people who we met at World Stroke Congress in Montreal,
Please reach out to us if you have not heard from us. The lead retrieval application has mysteriously “lost” our last 1.5 days of scans. We are working with them to hopefully recover the data, but for the moment, we are regrettably without your contact information.
We look forward to hearing from you,
Anne Vivian-Scott & Paul St. John
avivianscott@bkintechnologies.com
Dexterit-E 3.7 is released!
July 2018
The Dexterit-E 3.7.0 release brings many improvements for usability, task development, and normative modeling. We are thrilled to be able to deliver such a long list of tangible improvements!
Dexterit-E Explorer 1.4.0 Released: latest KINARM Standard Test analysis available now!
We are happy to announce the release of Dexterit-E Explorer 1.4.0!
ISO 13485:2016 Certification achieved!
BKIN has successfully renewed their ISO 13485 certification for another three year period. With this re-certification we were also able to transition to the latest 2016 standard – representing the best practice in quality management system implementation for manufacturers of medical devices.
RehabWeek 2017: Dr. Sean Dukelow speaks about his research with KINARM.
Dr Sean Dukelow, July 18, 2017
Long-time KINARM Lab user, Dr. Sean Dukelow, spoke at the International Neurorehabilitation Symposium in London, UK last week. INRS was one of four conferences that bound together for the biennial installment of RehabWeek. In his session, he described his research related to identifying and quantifying neurological impairments from stroke, concussion, CP and other disorders. He spoke of his long-term longitudinal study monitoring outcomes from over 100 subjects with stroke. Over the 6 month period he noted clear differences between early responders, late responders and non-responders. His results highlight the need for more sensitive, targeted identification of sensory and motor deficits to optimize rehabilitation after stroke. Further he has noted that the trajectory of recovery for some individuals with mild to moderate stroke may be much longer than previously considered. underlined the need for better characterization of impairments post stroke (Semrau, et al, 2015).
Semrau, J.A., Herter, T.M., Scott, S.H., Dukelow, S.P. (2015) Examining Differences in Patterns of Sensory and Motor Recovery After Stroke With Robotics Stroke 2015 Dec; DOI:10.1161/STROKEAHA.115.010750
Dexterit-E 3.6.3 released
Dexterit-E 3.6.3
July, 2017
Dexterit-E 3.6.3 has several important updates for usability, stability and maintenance. This is considered a highly recommended update.
American Academy of Neurology 69th Annual Meeting
Boston, Massachusetts – April 22 – 28, 2017
AAN will be our first trade show in the Boston area, presenting a great opportunity for clinician scientists in the Boston area to try KINARM Standard Tests.
We look forward to welcoming you to booth #128 !
AAN 2015, Wasghington, DC